A trial of flunarizine in the treatment of duchenne muscular dystrophy
β Scribed by Dr. David J. Dick; David Gardner-medwin; Peter G. Gates; Mary Gibson; Judy M. Simpson; Timothy J. Walls
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 491 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0148-639X
No coin nor oath required. For personal study only.
β¦ Synopsis
Twenty-seven boys with Duchenne muscular dystrophy (DMD) entered a double-blind controlled trial of treatment with the calcium antagonist flunarizine. They were matched for age and disability. At monthly intervals, muscle power, functional ability, locomotor score, contractures, and forced vital capacity were measured by a team not involved in clinical care. Over a period of 1 year, flunarizine in a dose of up to 0.25 mglkglday had no effect on the clinical course of the disease.
π SIMILAR VOLUMES
## Abstract We studied the reliability of a series of endpoints in an evaluation of subjects with Duchenne muscular dystrophy (DMD). The endpoints included quantitative muscle tests (QMTs), timed function tests, forced vital capacity (FVC), and manual muscle tests (MMT). Thirtyβone ambulatory subje
The series elastic component (SEC) of Hill's muscle model is sensitive to a modification in muscle functional demand. In this study, SEC stiffness was quantified from quick-released movements in knee extensors of Duchenne muscular dystrophy (DMD) boys to look for possible modifications with the stag